4-(Dimethoxymethyl)-2-(methylsulfonyl)pyrimidine

Catalog No.: 
ACVPYB254
CAS No.: 
874279-26-2
Molecular Formula: 
C8H12N2O4S
Molecular Weight: 
232.26
4-(Dimethoxymethyl)-2-(methylsulfonyl)pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$140.00InquiryInquiry
250mg95%$209.00InquiryInquiry
1g95%$521.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(Dimethoxymethyl)-2-(methylsulfonyl)pyrimidine
IUPAC Name4-(dimethoxymethyl)-2-(methylsulfonyl)pyrimidine
MDL No.MFCD27931047
Molecular FormulaC8H12N2O4S
Molecular Weight232.26
SMILESO=S(C1=NC=CC(C(OC)OC)=N1)(C)=O
InChI KeyMEDAIGDHJAKXIN-UHFFFAOYSA-N
Synonym4-(Dimethoxymethyl)-2-(methylsulfonyl)pyrimidine;Pyrimidine, 4-(dimethoxymethyl)-2-(methylsulfonyl)-
CAS No.874279-26-2
PubChem CID57937551

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACVPYB254 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPFVC876 route compound structure diagram
    ACPFVC876180869-36-7In Stock
  2. Then
  3. ACVPYB254 route product structure diagram
    ACVPYB254874279-26-2
Inquiry

2. ACVPYB254 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPFVC876 route compound structure diagram
    ACPFVC876180869-36-7In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVPYB254 route product structure diagram
    ACVPYB254874279-26-2
Inquiry

3. ACVPYB254 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPFVC876 route compound structure diagram
    ACPFVC876180869-36-7In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVPYB254 route product structure diagram
    ACVPYB254874279-26-2
Inquiry

Comments (0)